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Abstract
Background: Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical 
practice. Elective electrical cardioversion is often performed in patients with persistent AF to 
attempt sinus rhythm (SR) restoration. However, AF recurrences are frequent after successful 
cardioversion and several predictors have been identified. 
Aim of the study:  The present study was designed to prospectively analyse the correlation 
between NT-pro-BNP levels and AF recurrence in consecutive patients referred for electrical 
cardioversion of persistent atrial fibrillation. 
Results: Forty consecutive patients referred for elective cardioversion of AF were enrolled in the 
study. Cardioversion restored sinus rhythm in 34/40 patients but 2 of them presented an early 
recurrence of AF before discharge. Patients were then followed for 6 months to assess AF 
recurrence. Cox regression analysis was performed using the parameters found predictive on 
univariate survival analysis (NT-pro-BNP quartiles, beta-blockers). The only independent 
predictor of AF recurrence on Cox-regression analysis was a level of NT-pro-BNP in the fourth 
quartile (HR 3.21 95%CI 1.26-8.14, p=0.014). On receiver operating curve (ROC) analysis, NT-
pro-BNP levels above 1707 pg/ml had a specificity of 92% (and a sensitivity of 36%) in 
predicting atrial fibrillation recurrence by 6 months. 
Conclusions: Baseline NT-pro-BNP levels are an independent predictor of AF recurrence at 6 
months follow-up in candidates for elective direct current cardioversion.
Key Words: NT-Pro-BNP,  Cardioversion, Persistent Atrial Fibrillation, Arrhythmia 
Recurrence
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Background
            Atrial fibrillation (AF), with an estimated prevalence of 2.3 million patients in the US, is 
the most common arrhythmia encountered in clinical practice and represents the first cause of 
hospitalization   for   rhythm   disturbances1,2.   Elective   electrical   cardioversion   represents   an 
important therapeutic option in patients with persistent AF to attempt sinus rhythm (SR) 
restoration. However, AF recurrences are frequent after successful cardioversion and several 
predictors have been identified including AF duration3-6, left atrial7,8  and left ventricular 
dimensions4,5,9,   left   ventricular   ejection   fraction,   echocardiographic   characteristics10-12, 
electrocardiographic features13,14, age5,6,8, gender15, body weight16, underlying cardiac disease4-
6,8, NYHA functional class5,19,20, previous relapses of AF17,18, and their association5.               
            Brain natriuretic peptide (BNP) is a molecule with vasodilative, diuretic and natriuretic 
activity, produced and secreted mainly by ventricular myocardium in response to stretching of 
cardiomyocytes21,22  thus  representing   a  sensitive  marker  of  left ventricular  end-diastolic 
pressure. BNP is synthesized in the cardiomyocytes as an aminoacidic chain (pro-BNP) which is 
enzimatically   cleaved   into   an   inactive   NH2
-  terminal   fragment23  (NT-proBNP)   and   the 
biologically active COOH-terminal fragment (BNP)24. Given its longer half-life (60-120 minutes 
vs. 22 minutes), NT-proBNP levels are more stable and less influenced by acute haemodynamic 
variations than BNP levels, and therefore reflect the mean values of left ventricular filling 
pressures over the previous 12 hours25,26. As left ventricular dysfunction and elevated filling 
pressure are associated with an increased probability of atrial fibrillation recurrence NT-pro-
BNP, has been identified as a strong predictor of atrial fibrillation recurrence in different clinical 
settings.   In   particular,   brain   natriuretic   peptide   predicted   AF   after   cardiac   pacemaker 
implantation for sick sinus syndrome27, postoperative AF in patients undergoing cardiac 
surgery28, sinus rhythm maintenance 2 weeks after cardioversion29 and AF recurrence in patients 
with NHYA functional classes I or II30.                                                                                          
            The present study was designed to prospectively analyse the correlation between NT-pro-
BNP levels and AF recurrence in consecutive patients referred for electrical cardioversion of 
persistent atrial fibrillation, irrespective of NHYA functional class.                              
   
Methods
Patient   population                                                                                      
            Sixty-four consecutive patients referred to the outpatient clinic of the cardiovascular 
medicine department of our Institution for elective cardioversion of persistent AF between 
January 2006 and December 2006 were prospectively screened for inclusion in the study. 
Twenty-four patients were excluded from the study due to chronic renal failure, known to affect 
NT-pro-BNP levels. The remaining forty patients gave their informed consent and represent the 
study population. The study was approved by the institutional review board of our hospital.
NT-pro-BNP  
            A blood sample was drawn shortly before cardioversion with the patient at rest in supine 
position, to assess the concentration of the NT-proBNP at baseline. NT-proBNP was assessed by 
ECLIA   method   (Immunoassay   in   Electrochemyluminscence)   and   Elecsys   1010/2010 
immunoanalyser.  
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Cardioversion
               Synchronized cardioversion was performed during deep sedation with intravenous 
propofol delivering a stepwise sequence of impedance compensating biphasic shocks as follows: 
first discharge 100J; in case of failure a second discharge was delivered at 150 J; in case of 
failure a third discharge was delivered a 200 J; in case of failure of a 200J biphasic shock, 
attempts were terminated and the electrical cardioversion classified as ineffective.               
Follow-up
            After elective cardioversion, patients were followed monthly for 6 months or until a 
common stopping date. Additional follow-up visits were performed at patient's request in the 
case   of   symptom   recurrence.                                                                            
End-point
            The primary end-point was AF recurrence at scheduled or additional follow-up visits in 
patients discharged in sinus rhythm after elective cardioversion. The secondary end-point was 
acute efficacy of elective cardioversion, defined as discharge from the outpatient clinic in sinus 
rhythm   after   cardioversion.                                                                                    
Statistical   analysis                                                                                  
            Normal distribution of data was verified with Kolmogorov-Smirnov test. Data showing a 
normal distribution are presented as mean ± SD. Non-Gaussian variables are presented as 
median   [range].   Categorical   data   are   presented   as   proportion   of   cases   or   percentages. 
Comparisons   between   pairs   of   Gaussian   variables   were   performed   with   Student   t-test. 
Comparisons between non-Gaussian variables were performed with Mann-Whitney or Wilcoxon 
signed-rank test, as appropriate. Comparisons of proportions between groups were performed 
with chi-square test or Fisher's exact test, as appropriate. Univariate survival analysis was 
performed with Kaplan-Meier method. Univariate survival analysis was performed exploring the 
effect of age (expressed as tertiles), gender, AF duration (expressed as tertiles), baseline NT-pro-
BNP levels (expressed as quartiles) ejection fraction (categorized as normal vs. depressed if 
below 50%), atrial dimensions (expressed as tertiles), NYHA functional class (I and II vs III and 
IV) use of beta blockers, class Ic antiarrhythmic drugs and amiodarone as predictors of AF 
recurrence. The level of significance of the differences among survival curves was assessed by 
Log-rank and Breslow tests. Multivariate survival analysis was performed by Cox regression 
analysis on those variables significantly affecting AF recurrence at univariate survival analysis. 
A ROC analysis has been planned to identify possible cut-offs to predict AF recurrence at 6 
months. Statistical analysis was performed with SPSS 13.0 software package.                  
Results
            Forty consecutive patients referred for elective cardioversion of AF were enrolled in the 
study and their baseline characteristics are summarized in  Table 1. Patient population was 
represented by 23 males and 17 females aged 66.4±11.4 years, with an AF duration of 6.5 (2-26) 
months. NHYA functional class was I in 17, II in 14, III in 8 and IV in 1 patient. NT-pro-BNP 
levels before elective cardioversion were 1002 pg/ml (357-8027).
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Table 1. Baseline characteristics. 
EF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LA: left atrial diameter.
 Acute   efficacy                                                                              
              Cardioversion restored sinus rhythm in 34/40 pts but 2 of them presented an early 
recurrence of AF before discharge. Age, gender, LV ejection fraction, LA dimensions, LV 
dimensions,   use   of   beta-blockers,   digoxin,   furosemide,   class   IC   antiarrhythmic   drugs, 
amiodarone, calcium-channel blockers, AF duration, cardiovascular risk factors and baseline 
NT-pro-BNP levels were similar in patients with successful and unsuccessful cardioversion at 
univariate analysis (Table 2).
Atrial   fibrillation   recurrence                                                                          
            The univariate influence of age (tertiles), gender, baseline NT-pro-BNP levels (quartiles), 
AF duration (tertiles), left ventricular ejection fraction (categorized as normal vs. depressed, if 
below 50%), atrial dimensions (tertiles), ventricular diameter (tertiles), NHYA functional class (I 
and II vs III and IV), use of beta blockers, class Ic antiarrhythmic drugs, amiodarone, digoxin, 
furosemide, calcium channel blockers as predictors of time to AF recurrence was assessed by 
survival analysis in patients discharged in sinus rhythm after elective cardioversion.             
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            Kaplan-Meier survival curves were significantly different across quartiles of NT-pro-
BNP levels (Log Rank Mantel-Cox  p=0.044; Breslow test p= 0.035; Taron-Ware p= 0.038). 
The results of the pre-specified comparisons between quartiles evidenced a higher recurrence 
rate in patients with NT-pro-BNP in the fourth quartile as compared to the first quartile (Log 
Rank Mantel-Cox   p=0.039; Breslow test p= 0.050; Taron-Ware p= 0.046). Kaplan-Meier 
survival curves (Figure 1) were also significantly different in pts treated with beta-blockers (Log 
Rank Mantel-Cox   p=0.037; Breslow test p= 0.053; Taron-Ware p= 0.043), with a higher 
recurrence rate in patients on treatment.
Table 2. Comparison of baseline characteristics in patients discharged in sinus rhythm compared 
to pts discharged in atrial fibrillation. 
EF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LA: left atrial diameter.
               Cox regression analysis was performed using the parameters found predictive at 
univariate survival analysis (NT-pro-BNP quartiles, beta-blockers). The only independent 
predictor of AF recurrence at Cox-regression analysis was a level of NT-pro-BNP in the fourth 
quartile (HR 3.21 95%CI 1.26-8.14, p=0.014).                                                                 
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Figure 1: Kaplan-Meier curves of atrial fibrillation recurrence (first quartile compared to fourth quartile)
Receiver   operating   curve   analysis                                                                    
            A ROC analysis of AF recurrence by 6 months as a function of baseline NT-pro-BNP 
levels has been performed. The area under the curve was 0.709 (95% C.I 0.568-0.849), p=0.009 
(Figure 2). An analysis of NT-pro-BNP levels cut-offs was carried-out. NT-pro-BNP levels 
above 1707 pg/ml had a specificity of 92% (and a sensitivity of 36%) in predicting atrial 
fibrillation   recurrence   by   6   months.                                                            
 
Figure 2: Receiver operating curve of NT-pro-BNP leveles as a predictor of AF recurrence
 
Discussion
            Atrial fibrillation is the most common arrhythmia encountered in clinical practice. After 
a diagnosis of persistent AF, a rate control or a rhythm control strategy is alternatively pursued 
in  individual  patients,   and  excellent  reviews  have  analysed  the relative  advantages   and 
disadvantages. When a rhythm control strategy is considered, an accurate pre-procedural 
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estimate of the probability of sinus rhythm maintenance after electrical cardioversion is likely to 
affect the decision. Several factors are known to be clearly predictive of poor results, as 
advanced  age,  enlarged  atrium,  depressed left ventricular  ejection  fraction,  high NYHA 
functional class, and numerous previous recurrences.                                                       
            Previous studies demonstrated that BNP levels, as a marker of left ventricular filling 
pressure, predict sinus rhythm maintainance 2 weeks after cardioversion29 and that BNP plasma 
levels are an independent predictor of AF recurrence in different populations including patients 
with NHYA functional class I or II30  submitted to electrical cardioversion.                           
            However these findings appear to be of limited clinical value when extended to the whole 
spectrum of patients with persistent AF referred for possible cardioversion either because of the 
short term follow-up  or  because limited  to  patient   in  NHYA  functional  class   I  or  II.
            Our study confirms previous findings and demonstrate that high NT-proBNP levels at 
baseline in candidates for elective cardioversion are independently predictive of AF recurrence 
at 6 months follow-up irrespectively of NYHA functional class.                               
               These findings suggest that assessment of BNP levels in candidates to electrical 
cardioversion may represent an important information to decide whether and when to perform 
attempts to restore sinus rhythm. In fact, as BNP levels mostly reflect left ventricular filling 
pressure and then atrial pressure and stretch, it can be suggested that therapy with drugs affecting 
filling pressure, such as diuretics and ACE-inhibitors or angiotensin-receptor blockers, could be 
modulated in order to reduce BNP levels thus increasing the success rate of cardioversion and 
sinus   rhythm   maintenance.   Accordingly   it   is   well   established   that   pre-treatment   with 
angiotensin-receptor blockers increase the probability of sinus rhythm maintenance in patients 
with persistent atrial fibrillation subjected to cardioversion31. Interestingly in our study ejection 
fraction was not predictive of AF recurrence: although we cannot exclude that the study sample 
was not large enough to demonstrate the well established role of ejection fraction, our findings 
suggest that the increase of left ventricular filling pressure, not necessarily reflecting a worse 
contractile function, represents the key player in determining atrial fibrillation occurrence and 
recurrence in patients with cardiac dysfunction.                                                                     
            Our findings have relevant clinical implications as they identify NT-pro-BNP levels as an 
important tool to estimate the probability of AF recurrence in the population of patients referred 
for electrical cardioversion, including patients with variable degrees of cardiac dysfunction and 
different NHYA functional classes. A low probability of sinus rhythm maintenance, as estimated 
on the basis of patients characteristics, including baseline NT-pro-BNP levels, might suggest the 
physician to prefer a rhythm control to a rate control strategy and possibly to adopt therapeutic 
strategies aimed to reduce left ventricular filling pressure, and therefore BNP levels, to increase 
the rate of success of cardioversion. Cut off levels suggesting inefficacy of cardioversion 
attempts   have   been   proposed,   which   need   to   be   confirmed   by   further   investigations.
Study   Limitations                                                                                            
            We want to recognize several limitations of our study. Recurrence of AF was detected at 
visits elicited by return of symptoms or at scheduled monthly visits, underestimating AF 
recurrences and giving an inaccurate estimation of time to recurrence. Even though no 
restrictions were set on NHYA class, only 28% of patients discharged in sinus rhythm were in 
NHYA   functional   III   or   IV   resulting   in   a   limited   contribution   to   our   case-mix.  
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Conclusions
            Baseline NT-proBNP levels are an independent predictor of AF recurrence at 6 months 
follow-up in candidates for elective direct current cardioversion.
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